EchoIQ Ltd

F:PL4

Business Description

Sector

Information Technology

Industry

Technology

Headquarters

Australia AU

IPO date

Dec 17, 2010

EchoIQ Ltd develops software that helps doctors and healthcare systems spot structural heart disease from routine echocardiogram studies. Its main product is a cloud-based analysis tool that reviews echo images and flags patterns that may point to conditions such as aortic stenosis. The company sells access to this software and related services to hospitals, imaging providers, and other healthcare organizations that want to improve diagnosis and triage.

The business makes money mainly through software licensing, subscription-style access, and enterprise agreements with clinical customers. In practice, EchoIQ sits between the imaging study and the final diagnosis: it does not make medical devices or run hospitals, but it turns existing scan data into decision support that doctors can use in their workflow. That makes it a software layer on top of a common test that is already widely used in cardiology.

What sets the company apart is its focus on a narrow medical problem rather than general-purpose artificial intelligence. Instead of trying to analyze all kinds of healthcare data, EchoIQ concentrates on echocardiograms and heart-valve disease, where earlier detection can change treatment choices and patient routing. For beginner investors, the key idea is that it sells specialized clinical software to healthcare institutions, and its value depends on whether those institutions adopt it into everyday care.